| 201 |
New Title 'Patenting Proteomics'
|
Patenting Proteomics
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 202 |
New Title 'Patentability Requirements for Nanotechnological Inventions'
|
Patentability Requirements for Nanotechnological Inventions
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 203 |
New Title 'Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions'
|
Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 204 |
New Title 'Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?'
|
Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 205 |
New Title 'Pandemien als Herausforderung für die Rechtsordnung'
|
Pandemien als Herausforderung für die Rechtsordnung
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 206 |
New Title 'OSCE Insights 2022'
|
"OSCE Insights 2022"
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 207 |
New Title 'OSCE Insights 2022'
|
OSCE Insights 2022
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 208 |
New Title 'OSCE Insights 2021'
|
OSCE Insights 2021
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 209 |
New Title 'OSCE Insights 2021'
|
OSCE Insights 2021
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|
| 210 |
New Title 'OSCE Insights 2020'
|
OSCE Insights 2020
|
Successful
|
New Title
|
-Empty-
|
-Empty-
|
-Empty-
|
2022-09-16 09:47
|
2022-09-16 09:47
|